Phase 4 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a successful TEER procedure (a minimally invasive heart valve repair), as confirmed by standard technical success measures
- People who have a medical reason requiring long-term blood-thinning (anticoagulation) medication
- People who are able and willing to follow the trial's procedures and schedule
- People who are willing to provide written consent to participate
- Women who could become pregnant must be using effective contraception from the time of consent until the end of the blood-thinning treatment period
- People whose blood-thinning treatment plan has been reviewed and approved by the trial investigator
Who may not be able to join:
- People with severely reduced kidney function, or those who require dialysis
- People who are experiencing significant ongoing bleeding or serious blood vessel complications following their TEER procedure
- People with a very low platelet count (a measure of blood clotting cells) below a certain level
- People who need another operation due to complications from their TEER procedure
- People who have had a bleed inside the brain within the past 12 months
- People who have had stomach or intestinal ulcers or bleeding within the past 12 months
- People with serious liver disease that affects the blood's ability to clot (such as advanced cirrhosis)
- People who have an allergy, intolerance, or medical reason preventing them from taking the study medications
- People who are currently taking part in another clinical trial of a drug or medical device, or have done so within the past 30 days
- People who have had a stroke or mini-stroke (TIA) within the past 6 weeks
- People who have a firm medical requirement to take both anticoagulant and antiplatelet medications together (for example, following a recent heart stent procedure)
- People with a life expectancy of less than 12 months
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiangbin Pan, MD,PhD, Chinese Academy of Medical Sciences, Fuwai Hospital
Phone: +86(10)88396666
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
All bleeding complications at 1 year after TEER
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.